Company Analysis

Harvard Bioscience, Inc. (HBIO)

Nasdaq: HBIO · Laboratory Analytical Instruments · Holliston, MA · filing with the SEC since 2000
Grade2.8
◀ Past 1.6● Present 3.1▶ Future 3.7

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 13, 2026Mar 14, 2025Mar 7, 2024Mar 9, 2023Mar 11, 2022Mar 12, 2021Mar 16, 2020Mar 18, 2019Mar 16, 2018Mar 17, 2017
Revenue86,55094,135112,250113,335118,904102,100116,176120,77477,407r104,521
Cost of revenue36,64039,36946,17952,51651,25244,05951,85457,59338,237r56,106
Gross profit49,91054,76666,07160,81967,65258,04164,32263,18139,170r48,415
Research and development8,82510,40611,76412,32910,7998,68510,71510,9885,6455,392
Sales and marketing19,21622,21224,060r25,04124,64219,91623,26424,44315,082r20,486
General and administrative17,74221,49322,757r24,49324,30523,50922,76021,38217,525r20,950
Total operating expenses98,49060,97764,17767,75265,58657,82063,94562,19739,805r51,412
Operating income-48,580-6,2111,894-6,9332,066221377984-635r-2,997
Interest expense3,6003,200·····5,367713639r
Interest income (expense), net-4,917-3,536r-3,591-2,548-1,540-4,831-5,410-5,367··
Other income (expense), net-2,656-325r-227302-666-806-469-3,592r-739r-179
Total non-operating income (expense)-8,806-5,454-4,450-2,246-2,206-7,513-5,879-8,959-1,986r-81
Income before income taxes-57,386-11,665-2,556-9,179-140-7,292-5,502-7,975-2,621r-3,078
Income tax expense-686740859337148518-815-3,676-605r1,229
Income from continuing operations······-4,687-4,299-2,016·
Income from discontinued operations·······1,3771,151·
Net income-56,700-12,405-3,415-9,516-288-7,810-4,687-2,922-865-4,307
Earnings per share, basic-1.28-0.28-0.08-0.23-0.01·-0.12-0.08-0.02-0.13
Earnings per share, diluted-1.28-0.28-0.08-0.23··-0.12-0.08-0.02-0.13
Earnings per share, basic and diluted····-0.01-0.20-0.12···
Weighted average shares, basic44,391,00043,538,00042,420,00041,413,00040,343,00038,640,000r37,813,58036,453,12634,753,32534,211,521
Weighted average shares, diluted44,391,00043,538,00042,420,00041,413,00040,343,00038,640,000r37,813,58036,453,12634,753,32534,211,521
Weighted average shares, basic and diluted····40,343,00038,640,00037,814,000···
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton HBIO · research, not advice